SELLAS Life Sciences (SLS) Non-Current Deferred Tax Liability (2015 - 2021)

SELLAS Life Sciences (SLS) has 7 years of Non-Current Deferred Tax Liability data on file, last reported at $152000.0 in Q4 2021.

• Non-Current Deferred Tax Liability for Q4 2021 came in at $152000.0, down 36.4% year-over-year; the trailing twelve-month figure through Dec 2021 was $152000.0 (down 36.4% YoY), and the FY2021 annual result was $152000.0, down 36.4% from the prior year.
• Non-Current Deferred Tax Liability fell to $152000.0 in Q4 2021 per SLS's latest filing, from $239000.0 in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $5.7 million in Q1 2017 and troughed at $152000.0 in Q4 2021.
• A 5-year average of $1.4 million and a median of $357000.0 in 2018 frame the typical range for Non-Current Deferred Tax Liability.
• The sharpest annual moves came in 2017 and 2019: Non-Current Deferred Tax Liability rose 4.49% in 2017, then slumped 79.27% in 2019.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $1.7 million in 2017, then tumbled by 78.66% to $357000.0 in 2018, then decreased by 26.61% to $262000.0 in 2019, then slipped by 8.78% to $239000.0 in 2020, then slumped by 36.4% to $152000.0 in 2021.
• Business Quant data shows SLS's Non-Current Deferred Tax Liability at $152000.0 in Q4 2021, $239000.0 in Q3 2021, and $239000.0 in Q2 2021.